Global Cell and Gene Therapy Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Rare Diseases 1.2.3 Oncology 1.2.4 Hematology 1.2.5 Cardiovascular 1.2.6 Ophthalmology 1.2.7 Neurology 1.2.8 Other Therapeutic Classes 1.3 Market by Application 1.3.1 Global Cell and Gene Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Pharmaceutical and Biotechnology Companies 1.3.3 Research and Academic Institutions 1.3.4 Contract Research Organizations (CROs) 1.3.5 Hospital 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Cell and Gene Therapy Market Perspective (2017-2028) 2.2 Cell and Gene Therapy Growth Trends by Region 2.2.1 Cell and Gene Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cell and Gene Therapy Historic Market Size by Region (2017-2022) 2.2.3 Cell and Gene Therapy Forecasted Market Size by Region (2023-2028) 2.3 Cell and Gene Therapy Market Dynamics 2.3.1 Cell and Gene Therapy Industry Trends 2.3.2 Cell and Gene Therapy Market Drivers 2.3.3 Cell and Gene Therapy Market Challenges 2.3.4 Cell and Gene Therapy Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Cell and Gene Therapy Players by Revenue 3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2017-2022) 3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cell and Gene Therapy Revenue 3.4 Global Cell and Gene Therapy Market Concentration Ratio 3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2021 3.5 Cell and Gene Therapy Key Players Head office and Area Served 3.6 Key Players Cell and Gene Therapy Product Solution and Service 3.7 Date of Enter into Cell and Gene Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans4 Cell and Gene Therapy Breakdown Data by Type 4.1 Global Cell and Gene Therapy Historic Market Size by Type (2017-2022) 4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2023-2028)5 Cell and Gene Therapy Breakdown Data by Application 5.1 Global Cell and Gene Therapy Historic Market Size by Application (2017-2022) 5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Cell and Gene Therapy Market Size (2017-2028) 6.2 North America Cell and Gene Therapy Market Size by Type 6.2.1 North America Cell and Gene Therapy Market Size by Type (2017-2022) 6.2.2 North America Cell and Gene Therapy Market Size by Type (2023-2028) 6.2.3 North America Cell and Gene Therapy Market Share by Type (2017-2028) 6.3 North America Cell and Gene Therapy Market Size by Application 6.3.1 North America Cell and Gene Therapy Market Size by Application (2017-2022) 6.3.2 North America Cell and Gene Therapy Market Size by Application (2023-2028) 6.3.3 North America Cell and Gene Therapy Market Share by Application (2017-2028) 6.4 North America Cell and Gene Therapy Market Size by Country 6.4.1 North America Cell and Gene Therapy Market Size by Country (2017-2022) 6.4.2 North America Cell and Gene Therapy Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe Cell and Gene Therapy Market Size (2017-2028) 7.2 Europe Cell and Gene Therapy Market Size by Type 7.2.1 Europe Cell and Gene Therapy Market Size by Type (2017-2022) 7.2.2 Europe Cell and Gene Therapy Market Size by Type (2023-2028) 7.2.3 Europe Cell and Gene Therapy Market Share by Type (2017-2028) 7.3 Europe Cell and Gene Therapy Market Size by Application 7.3.1 Europe Cell and Gene Therapy Market Size by Application (2017-2022) 7.3.2 Europe Cell and Gene Therapy Market Size by Application (2023-2028) 7.3.3 Europe Cell and Gene Therapy Market Share by Application (2017-2028) 7.4 Europe Cell and Gene Therapy Market Size by Country 7.4.1 Europe Cell and Gene Therapy Market Size by Country (2017-2022) 7.4.2 Europe Cell and Gene Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Cell and Gene Therapy Market Size (2017-2028) 8.2 Asia-Pacific Cell and Gene Therapy Market Size by Type 8.2.1 Asia-Pacific Cell and Gene Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Cell and Gene Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Cell and Gene Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific Cell and Gene Therapy Market Size by Application 8.3.1 Asia-Pacific Cell and Gene Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Cell and Gene Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Cell and Gene Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region 8.4.1 Asia-Pacific Cell and Gene Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Cell and Gene Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cell and Gene Therapy Market Size (2017-2028) 9.2 Latin America Cell and Gene Therapy Market Size by Type 9.2.1 Latin America Cell and Gene Therapy Market Size by Type (2017-2022) 9.2.2 Latin America Cell and Gene Therapy Market Size by Type (2023-2028) 9.2.3 Latin America Cell and Gene Therapy Market Share by Type (2017-2028) 9.3 Latin America Cell and Gene Therapy Market Size by Application 9.3.1 Latin America Cell and Gene Therapy Market Size by Application (2017-2022) 9.3.2 Latin America Cell and Gene Therapy Market Size by Application (2023-2028) 9.3.3 Latin America Cell and Gene Therapy Market Share by Application (2017-2028) 9.4 Latin America Cell and Gene Therapy Market Size by Country 9.4.1 Latin America Cell and Gene Therapy Market Size by Country (2017-2022) 9.4.2 Latin America Cell and Gene Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Cell and Gene Therapy Market Size (2017-2028) 10.2 Middle East & Africa Cell and Gene Therapy Market Size by Type 10.2.1 Middle East & Africa Cell and Gene Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Cell and Gene Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa Cell and Gene Therapy Market Size by Application 10.3.1 Middle East & Africa Cell and Gene Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Cell and Gene Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Cell and Gene Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country 10.4.1 Middle East & Africa Cell and Gene Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Cell and Gene Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Amgen Inc. 11.1.1 Amgen Inc. Company Details 11.1.2 Amgen Inc. Business Overview 11.1.3 Amgen Inc. Cell and Gene Therapy Introduction 11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.1.5 Amgen Inc. Recent Developments 11.2 bluebird bio, Inc. 11.2.1 bluebird bio, Inc. Company Details 11.2.2 bluebird bio, Inc. Business Overview 11.2.3 bluebird bio, Inc. Cell and Gene Therapy Introduction 11.2.4 bluebird bio, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.2.5 bluebird bio, Inc. Recent Developments 11.3 Dendreon Pharmaceuticals LLC. 11.3.1 Dendreon Pharmaceuticals LLC. Company Details 11.3.2 Dendreon Pharmaceuticals LLC. Business Overview 11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction 11.3.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2017-2022) 11.3.5 Dendreon Pharmaceuticals LLC. Recent Developments 11.4 Fibrocell Science, Inc. 11.4.1 Fibrocell Science, Inc. Company Details 11.4.2 Fibrocell Science, Inc. Business Overview 11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Introduction 11.4.4 Fibrocell Science, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.4.5 Fibrocell Science, Inc. Recent Developments 11.5 Human Stem Cells Institute 11.5.1 Human Stem Cells Institute Company Details 11.5.2 Human Stem Cells Institute Business Overview 11.5.3 Human Stem Cells Institute Cell and Gene Therapy Introduction 11.5.4 Human Stem Cells Institute Revenue in Cell and Gene Therapy Business (2017-2022) 11.5.5 Human Stem Cells Institute Recent Developments 11.6 Kite Pharma, Inc. 11.6.1 Kite Pharma, Inc. Company Details 11.6.2 Kite Pharma, Inc. Business Overview 11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction 11.6.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.6.5 Kite Pharma, Inc. Recent Developments 11.7 Kolon TissueGene, Inc. 11.7.1 Kolon TissueGene, Inc. Company Details 11.7.2 Kolon TissueGene, Inc. Business Overview 11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction 11.7.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.7.5 Kolon TissueGene, Inc. Recent Developments 11.8 Novartis AG 11.8.1 Novartis AG Company Details 11.8.2 Novartis AG Business Overview 11.8.3 Novartis AG Cell and Gene Therapy Introduction 11.8.4 Novartis AG Revenue in Cell and Gene Therapy Business (2017-2022) 11.8.5 Novartis AG Recent Developments 11.9 Orchard Therapeutics plc. 11.9.1 Orchard Therapeutics plc. Company Details 11.9.2 Orchard Therapeutics plc. Business Overview 11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Introduction 11.9.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.9.5 Orchard Therapeutics plc. Recent Developments 11.10 Organogenesis Holdings Inc. 11.10.1 Organogenesis Holdings Inc. Company Details 11.10.2 Organogenesis Holdings Inc. Business Overview 11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Introduction 11.10.4 Organogenesis Holdings Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.10.5 Organogenesis Holdings Inc. Recent Developments 11.11 Pfizer, Inc. 11.11.1 Pfizer, Inc. Company Details 11.11.2 Pfizer, Inc. Business Overview 11.11.3 Pfizer, Inc. Cell and Gene Therapy Introduction 11.11.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.11.5 Pfizer, Inc. Recent Developments 11.12 RENOVA THERAPEUTICS 11.12.1 RENOVA THERAPEUTICS Company Details 11.12.2 RENOVA THERAPEUTICS Business Overview 11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Introduction 11.12.4 RENOVA THERAPEUTICS Revenue in Cell and Gene Therapy Business (2017-2022) 11.12.5 RENOVA THERAPEUTICS Recent Developments 11.13 Shanghai Sunway Biotech Co., Ltd., 11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Details 11.13.2 Shanghai Sunway Biotech Co., Ltd., Business Overview 11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Introduction 11.13.4 Shanghai Sunway Biotech Co., Ltd., Revenue in Cell and Gene Therapy Business (2017-2022) 11.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments 11.14 Sibiono GeneTech Co. Ltd., 11.14.1 Sibiono GeneTech Co. Ltd., Company Details 11.14.2 Sibiono GeneTech Co. Ltd., Business Overview 11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Introduction 11.14.4 Sibiono GeneTech Co. Ltd., Revenue in Cell and Gene Therapy Business (2017-2022) 11.14.5 Sibiono GeneTech Co. Ltd., Recent Developments 11.15 Spark Therapeutics, Inc. 11.15.1 Spark Therapeutics, Inc. Company Details 11.15.2 Spark Therapeutics, Inc. Business Overview 11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Introduction 11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Business (2017-2022) 11.15.5 Spark Therapeutics, Inc. Recent Developments 11.16 Vericel Corporation 11.16.1 Vericel Corporation Company Details 11.16.2 Vericel Corporation Business Overview 11.16.3 Vericel Corporation Cell and Gene Therapy Introduction 11.16.4 Vericel Corporation Revenue in Cell and Gene Therapy Business (2017-2022) 11.16.5 Vericel Corporation Recent Developments 11.17 ViroMed Co., Ltd. 11.17.1 ViroMed Co., Ltd. Company Details 11.17.2 ViroMed Co., Ltd. Business Overview 11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Introduction 11.17.4 ViroMed Co., Ltd. Revenue in Cell and Gene Therapy Business (2017-2022) 11.17.5 ViroMed Co., Ltd. Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer